Elmir Omerovic is a senior consultant cardiologist and Professor of Cardiology at Göteborgs University. Since 2007 he is head of the Heart Group at The Wallenberg Laboratory for Cardiovascular research at Sahlgrenska Academy, Gothenburg, Sweden. Professor Omerovic is a board-certified cardiologist with training at the Sahlgrenska University Hospital. He has a broad clinical and scientific interest in the entire field of cardiovascular medicine from prevention (hypertension, lipid disorders, diabetes) to coronary artery disease (angina pectoris, myocardial infarction, acute post-infarction heart failure) to chronic heart failure. His particular research interest is taktosubo syndrome and observational studies based on national registries of cardiovascular diseases in Sweden (SWEDEHEART/SCAAR). He is trained interventional cardiologist regularly performing diagnostic coronary angiographies and percutaneous coronary procedures.
ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.
Our mission: To reduce the burden of cardiovascular disease